Arthroscopy Arthrodesis Gleno-humeral
Conditions
Brief summary
Arthrodesis shoulder blade/humerus under arthroscopy. Implementation of an external fixative spray at the proximal level in the thorn of the scapula and distal in the diaphysis humerus.
Detailed description
This trial is about the arthrodesis shoulder blade/humerus under arthroscopy. The main aim of this study is to be able to carry out a fusion scapula-humeral supplements in 6 months. It is required to provide the benefice risk over to reduce the hospitalisation 48 hours.
Interventions
The shoulder surgery will be realized under arthroscopy only
Sponsors
Study design
Eligibility
Inclusion criteria
* Patient having a deficit scapula-humeral mobility * Impossibility of being operated for a preserving nervous surgery * Patient affiliation with a social security * Patient who signed inform consent
Exclusion criteria
* Patient with No mobility in all the articulations of the shoulder * Callus malunion of the higher end of the humerus or the glen of the scapula * Unable to sign an inform consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Radiological fusion gleno humeral on side and front view after the 6th month of the arthroscopy interventional | 6 months | This outcome will be considered like a success if the investigators get a continuous bone matrix between the humeral head and glenoid on the scapula and bone frame continues between the humeral head and the acromion. This evaluation will be done by radiographies. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Blood loss | 3 days | The blood loss during and after the surgery will be calculated and will be considered like a success if the total blood loss are less than 600ml. |
Countries
France